BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile
communications, and NantHealth, a cloud-based information technology
provider combining science and big data to transform healthcare, today
announced the first secure clinical genome browser that gives doctors
unprecedented access to patients’ genetic data on the BlackBerry®
Passport smartphone – the NantOmics Cancer Genome Browser™.
The NantOmics Cancer Genome Browser platform on the BlackBerry Passport
enables deep, interactive reporting on genomics data for physicians and
other treatment providers in clinical settings – for example, giving
oncologists a powerful view into the individual genetic alternations
that make each patient’s disease unique and highlighting relevant
Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the MiSeq
FGx Forensic Genomics System , the first fully validated forensic
next-generation sequencing (NGS) system, which simultaneously
interrogates short tandem repeats (STR) and other valuable genetic
markers, including single nucleotide polymorphisms (SNPs), to provide
informative DNA profiles.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.